Related Experiment Videos
Pseudosemiglabrin, a platelet aggregation inhibitor from tephrosia semiglabra
L T Jonathan1, M Gbeassor, C T Che
1Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago 60680.
Journal of Natural Products
|November 1, 1990
Summary
Two novel 7-oxygenated-8-prenylflavones were isolated from Tephrosia semiglabra. (-)-Pseudosemiglabrin demonstrated in vitro inhibitory effects on human platelet aggregation.
Area of Science:
- Phytochemistry
- Pharmacology
Background:
- Tephrosia semiglabra is a plant species known for its diverse chemical constituents.
- Flavonoids are a class of plant secondary metabolites with a wide range of biological activities.
Purpose of the Study:
- To isolate and characterize bioactive compounds from Tephrosia semiglabra.
- To evaluate the in vitro inhibitory effects of isolated compounds on human platelet aggregation.
Main Methods:
- Bioassay-directed fractionation of a methanol extract of Tephrosia semiglabra.
- Isolation and structural elucidation of two 7-oxygenated-8-prenylflavones, (-)-pseudosemiglabrin and (-)-semiglabrin.
- In vitro assessment of human platelet aggregation inhibition.
Main Results:
- (-)-Pseudosemiglabrin and (-)-semiglabrin were successfully isolated and identified.
- (-)-Pseudosemiglabrin exhibited significant in vitro inhibitory effects on human platelet aggregation.
Conclusions:
- (-)-Pseudosemiglabrin is a bioactive compound with potential antiplatelet properties.
- Further investigation into the mechanism of action and therapeutic potential of (-)-pseudosemiglabrin is warranted.